These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 36733239)
1. The Advances in Chitosan-based Drug Delivery Systems for Colorectal Cancer: A Narrative Review. Ali DS; Othman HO; Anwer ET Curr Pharm Biotechnol; 2023; 24(12):1554-1559. PubMed ID: 36733239 [TBL] [Abstract][Full Text] [Related]
2. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment. Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620 [TBL] [Abstract][Full Text] [Related]
3. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review. Kamath PR; Sunil D Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780 [TBL] [Abstract][Full Text] [Related]
4. Prospects and challenges of anticancer agents' delivery via chitosan-based drug carriers to combat breast cancer: a review. Wang G; Li R; Parseh B; Du G Carbohydr Polym; 2021 Sep; 268():118192. PubMed ID: 34127212 [TBL] [Abstract][Full Text] [Related]
5. Cromolyn chitosan nanoparticles as a novel protective approach for colorectal cancer. Motawi TK; El-Maraghy SA; ElMeshad AN; Nady OM; Hammam OA Chem Biol Interact; 2017 Sep; 275():1-12. PubMed ID: 28732690 [TBL] [Abstract][Full Text] [Related]
6. Advances in chitosan-based nanoparticles for oncotherapy. Zhang E; Xing R; Liu S; Qin Y; Li K; Li P Carbohydr Polym; 2019 Oct; 222():115004. PubMed ID: 31320066 [TBL] [Abstract][Full Text] [Related]
7. Chitosan and Wnt/β-catenin Signaling Pathways in Different Cancers. Eslahi M; Sadoughi F; Asemi Z; Yousefi B; Mansournia MA; Hallajzadeh J Comb Chem High Throughput Screen; 2021; 24(9):1323-1331. PubMed ID: 33081676 [TBL] [Abstract][Full Text] [Related]
8. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract. Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846 [TBL] [Abstract][Full Text] [Related]
9. ROS-Responsive Chitosan Coated Magnetic Iron Oxide Nanoparticles as Potential Vehicles for Targeted Drug Delivery in Cancer Therapy. Ayyanaar S; Balachandran C; Bhaskar RC; Kesavan MP; Aoki S; Raja RP; Rajesh J; Webster TJ; Rajagopal G Int J Nanomedicine; 2020; 15():3333-3346. PubMed ID: 32494133 [TBL] [Abstract][Full Text] [Related]
10. The effects of chitosan-based materials on glioma: Recent advances in its applications for diagnosis and treatment. Eslahi M; Dana PM; Asemi Z; Hallajzadeh J; Mansournia MA; Yousefi B Int J Biol Macromol; 2021 Jan; 168():124-129. PubMed ID: 33275978 [TBL] [Abstract][Full Text] [Related]
11. Chitosan-based nanodelivery systems for cancer therapy: Recent advances. Narmani A; Jafari SM Carbohydr Polym; 2021 Nov; 272():118464. PubMed ID: 34420724 [TBL] [Abstract][Full Text] [Related]
12. Advances in Chitosan-based Drug Delivery Systems in Melanoma: A Narrative Review. Dana PM; Hallajzadeh J; Asemi Z; Mansournia MA; Yousefi B Curr Med Chem; 2024; 31(23):3488-3501. PubMed ID: 37202890 [TBL] [Abstract][Full Text] [Related]
13. Micelles as potential drug delivery systems for colorectal cancer treatment. Fatfat Z; Fatfat M; Gali-Muhtasib H World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871 [TBL] [Abstract][Full Text] [Related]
14. Development of enteric-coated, biphasic chitosan/HPMC microcapsules for colon-targeted delivery of anticancer drug-loaded nanoparticles. Ma Y; Thurecht KJ; Coombes AGA Int J Pharm; 2021 Sep; 607():121026. PubMed ID: 34418474 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable disulfide crosslinked chitosan/stearic acid nanoparticles for dual drug delivery for colorectal cancer. Sood A; Gupta A; Bharadwaj R; Ranganath P; Silverman N; Agrawal G Carbohydr Polym; 2022 Oct; 294():119833. PubMed ID: 35868778 [TBL] [Abstract][Full Text] [Related]
16. Research Progress of Chitosan-based Multifunctional Nanoparticles in Cancer Targeted Therapy. Lai C; Lin S; Liu W; Jin Y Curr Med Chem; 2024; 31(21):3074-3092. PubMed ID: 37062062 [TBL] [Abstract][Full Text] [Related]
17. Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer. Abdellatif AAH; Alshubrumi AS; Younis MA AAPS PharmSciTech; 2024 Jan; 25(1):23. PubMed ID: 38267656 [TBL] [Abstract][Full Text] [Related]
19. Development of chitosan/halloysite/graphitic‑carbon nitride nanovehicle for targeted delivery of quercetin to enhance its limitation in cancer therapy: An in vitro cytotoxicity against MCF-7 cells. Sabzini M; Pourmadadi M; Yazdian F; Khadiv-Parsi P; Rashedi H Int J Biol Macromol; 2023 Jan; 226():159-171. PubMed ID: 36435458 [TBL] [Abstract][Full Text] [Related]
20. Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery. Samprasit W; Opanasopit P; Chamsai B Pharm Dev Technol; 2021 Mar; 26(3):362-372. PubMed ID: 33423571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]